Cellebrite DI (CLBT) Non-Current Deffered Revenue (2020 - 2026)

Cellebrite DI has reported Non-Current Deffered Revenue for 7 years, with the latest figure at $49.9 million in Q2 2026.

• On a quarterly basis, Non-Current Deffered Revenue rose 13.25% year-over-year to $49.9 million in Q2 2026; TTM through Jun 2026 was $49.9 million, a 13.25% increase from a year earlier, with the FY2025 full-year figure at $49.5 million, up 9.46% from the prior year.
• Non-Current Deffered Revenue was $49.9 million for Q2 2026 at Cellebrite DI, roughly flat from $50.1 million in the prior quarter.
• The five-year high for Non-Current Deffered Revenue was $50.1 million in Q1 2026, with the low at $35.2 million in Q1 2022.
• Average Non-Current Deffered Revenue over 5 years is $44.2 million, with a median of $44.8 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue jumped 37.58% in 2023, then slipped 13.05% in 2024.
• Over 5 years, Non-Current Deffered Revenue stood at $42.2 million in 2022, then gained by 11.68% to $47.1 million in 2023, then declined by 3.93% to $45.2 million in 2024, then rose by 9.46% to $49.5 million in 2025, then gained by 0.84% to $49.9 million in 2026.
• The last three Non-Current Deffered Revenue figures came in at $49.9 million (Q2 2026), $50.1 million (Q1 2026), and $49.5 million (Q4 2025), per Business Quant data.